Get started
Author

Nathalie Imbault

Safety and immunogenicity of GMZ2 — a MSP3–GLURP fusion protein malaria vaccine candidate
2009 · Meral Esen, Peter G. Kremsner, et al. · Vaccine · 112
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults
2007 · Nilima Kshirsagar, Naidu Mur, et al. · Vaccine · 82
A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children
2011 · Sabine Bélard, Saadou Issifou, et al. · PLoS ONE · 70
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon
2010 · Benjamin Mordmüller, Katja Szywon, et al. · Vaccine · 70
Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175
2015 · Chetan E. Chitnis, Paushali Mukherjee, et al. · PLoS ONE · 47
PDF
European Vaccine Initiative: lessons from developing malaria vaccines
2011 · Mark J Geels, Egeruan B Imoukhuede, et al. · Expert Review of Vaccines · 20
PDF
Roadmap for the establishment of a European vaccine R&D infrastructure
2014 · Odile Leroy, Mark Geels, et al. · Vaccine · 13
PDF
Correction: Phase I Clinical Trial of a Recombinant Blood Stage Vaccine Candidate for Plasmodium falciparum Malaria Based on MSP1 and EBA175
2015 · Chetan E. Chitnis, Paushali Mukherjee, et al. · PLoS ONE · 10
PDF
Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo
2024 · Hugo Kavunga-Membo, Deborah Watson-Jones, et al. · Vaccines · 8
PDF
The promise, problems, and pitfalls of including pregnant women in clinical trials of Lassa fever vaccine: a qualitative assessment of sub-Sahara Africa investigators' perception.
2022 · Kolawole Akeem Salami, Henshaw Eyambe Mandi, et al. · PubMed · 8
A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries
2020 · Kolawole Salami, Nathalie Imbault, et al. · Pilot and Feasibility Studies · 6
PDF
Immunogenicity of an Extended Dose Interval for the Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children in the Democratic Republic of the Congo
2024 · Edward Man-Lik Choi, Kambale Kasonia, et al. · Vaccines · 5
PDF
European malaria vaccine initiative: Portfolio and perspectives for the future
2010 · Egeruan Babatunde Imoukhuede, Roland Ventura, et al. · Human Vaccines · 4
PDF
Building Partnerships and Confronting Challenges: Implementation of an Ebola Virus Vaccine Clinical Study During an Outbreak in the Democratic Republic of the Congo
2024 · Daniel G. Bausch, Hugo Kavunga-Membo, et al. · Sustainable development goals series · 1
PDF
The Promise, Problems, and Pitfalls of Including Pregnant Women in Lassa Fever Vaccine Clinical Trials: A Qualitative Analysis of Sub-Sahara Africa Investigators' Perception
2021 · Kolawole A Salami, Henshaw E Mandi, et al. · Research Square · 1
PDF
Correction to: Building Partnerships and Confronting Challenges: Implementation of an Ebola Virus Vaccine Clinical Study During an Outbreak in the Democratic Republic of the Congo
2025 · Daniel G. Bausch, Hugo Kavunga-Membo, et al. · Sustainable development goals series
PDF
Oc-8724 New Vaccines for a Safer World
2019 · Nathalie Imbault, Rachel Grant · BMJ Global Health
PDF
Works count: 21
Citation count: 457
H-index: 8
I10-index: 8
Year
Topic
Type